RESEARCH LIBRARY
A quick map of the peer-reviewed literature for each peptide we carry — graded by how much research exists and the areas it's been studied in. Tap a card for the full study list. Educational reference only; sold strictly for laboratory research, not for human or animal use.
Retatrutide
Extensively StudiedBacked by published Phase 2 randomized trials; additional Phase 3 results are reading out through 2026.
BPC-157
Emerging ResearchEvidence is predominantly preclinical (animal models) and recent reviews; large human clinical trials are not yet available.
TB-500
Well ResearchedMost human data come from full-length thymosin β4 programs; the TB-500 fragment itself is studied largely in preclinical models.
CJC-1295 DAC
Emerging ResearchDirect human data is limited to early pharmacology trials; recent literature focuses on the broader GHRH-analog class.
Semax
Well ResearchedClinically used in Russia; recent peer-reviewed work is largely preclinical (stroke, cognition, neuroprotection).